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ABSTRACT 
 
 
Context: Universal Newborn Hearing Screening (UNHS) is not routinely performed in South 
African state-run hospitals. Early identification of hearing impairments and subsequent early 
intervention, results in improved speech and language development and overall better cognitive 
outcomes. 
Objectives: We aim to investigate the number of neonates which could be screened for hearing 
deficits using the currently available staff and equipment, at a single institution over a set period 
of time, and to describe the outcomes of the screening test.  
Design, setting and patients: A prospective feasibility assessment conducting screening 
hearing tests on neonates born at a secondary level hospital in Johannesburg, South Africa, 
during a three month period. 
Methods: Hospital-based Audiologists conducted a risk factor assessment, otoscopic 
examinations and Distortion-Product Otoacoustic emissions (DPOAE) testing on the ears of 
eligible neonates. Repeat testing was carried out on neonates who presented with refer findings 
on the screening test. Testing time and challenges encountered were recorded. 
Analysis:  Data was entered into Microsoft Office Excel ©, and later analysed using STATA 
I/C version 11©.  
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Results: Of 2740 neonates born during the study period, 490 (17.9%) were identified for 
screening and DPOAE testing was conducted on 121 (4.4%). The majority (74.4%) were 
screened in the first 24 hours of life. Repeat testing was required in 57 (47.1%) neonates, but 
only 20 returned for follow-up. The presence of vernix caseosa and excessive ambient noise 
were factors negatively impacting on the screening process. No maternal or neonatal risk factors 
were found to be significantly associated with refer findings on the screening test. 
Conclusion: The existing staff was unable to screen a significant number of neonates using 
DPOAE testing during the study period. Implementation of UNHS under current circumstances 
at this research site would likely not be feasible.  
 
 
 
 
Key words: Universal Newborn Hearing Screening; feasibility study; resource-poor settings; 
otoacoustic emission; hearing loss. 
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1.0 Introduction 
1.1 Background 
The presence of a hearing impairment in the newborn baby may result in devastating long-term 
consequences. These include communication delays, emotional disturbances, cognitive deficits 
and, subsequently, future employment difficulties and career limitations (1). Failure to make the 
diagnosis within the first six months of life results in the failure to achieve vital stages in speech 
and language development, and consequently, a poorer prognosis for the individual  with regard 
to their cognitive abilities (2). An expected language delay of two to four years is associated 
with hearing loss that is detected in infants after the age of six months (3). It is therefore 
imperative to detect hearing impairments as early as possible in neonates and infants. 
 
The incidence figures for hearing impairments in resource-poor countries are estimated at 6 per 
1000 live births compared to an estimated incidence of 2-4 per 1000 in industrialised countries 
(1). The major relevance of detecting sensorineural hearing loss in the newborn is that it is much 
more prevalent than any other congenital disorder. Congenital hypothyroidism has a reported 
prevalence of  50 per 100 000 infants compared to the 260 per 100 000 infants affected with a 
sensorineural hearing loss, yet screening for congenital hypothyroidism is more commonly done 
(4). The aetiology of these congenital or early-onset hearing impairments are commonly genetic 
in origin or secondary to a perinatal insult such as congenital infections, birth asphyxia, 
hyperbilirubinemia or low birth weight (5). The high incidence of hearing impairment, 
especially in resource-poor countries, necessitates some early form of identification so that the 
necessary interventions can be implemented to limit the devastating long-term complications. 
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Prior to 1993, in the United States of America (USA), only high risk infants were assessed for 
hearing loss and the Auditory Brainstem Response (ABR) was the preferred method used (6). 
Since the recommendation from the National Institute of Health in the USA that all infants 
should be screened within the first three months of life, all of the 51 states in the USA have 
successfully implemented Universal Newborn Hearing Screening (UNHS) programs (7).  
 
Currently no formalised system of newborn hearing screening exists at state-run hospitals in 
Johannesburg, South Africa. Referrals to the audiology department for hearing screening are 
subsequent to follow-up in the neonatal clinics, where “high risk” individuals are identified and 
monitored. Risk factors for neonatal hearing loss have been identified by the Joint Committee 
of Infant Hearing (JCIH) in the USA, and infectious diseases more prevalent in South Africa, 
namely human immunodeficiency virus (HIV) and malaria, have also been identified as risk 
factors (8-10). 
 
Although this system of targeted screening is viewed as a positive step toward Early Hearing 
Detection and Intervention (EHDI), it has been documented to have significant flaws. Studies 
have shown that by screening only those infants considered “high-risk”, approximately 50% of 
infants with hearing impediments would be missed (6). Thus, increased efforts are warranted 
towards ensuring that every baby is screened for hearing impairment and not only those with 
identified risk factors; particularly when the risk factors may also not be contextually relevant. 
 
The World Health Organization (WHO) has stipulated that in order for a screening programme 
to be successful it needs to meet the following criteria (11): 
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- the condition screened for should be an important health problem for the individual and 
community;  
- there should be an acceptable screening test and treatment available; 
- early commencement of treatment should be more beneficial than if treatment is commenced 
at a later time. EHDI fulfils this criterion as early interventions aid the child in attaining their 
appropriate pre-linguistic skills;  
- The cost of screening and the provision of an intervention should be economically feasible in 
relation to the overall medical care. This may be one of the reasons why UNHS has not as yet 
been successfully implemented in developing countries, as too many other life-threatening 
health issues such as malnutrition and poor obstetric care, compete for funds (12).  
 
South Africa has made advances towards achieving UNHS by issuing a Hearing Screening 
Position Statement which is based on the year 2000 Position statement of the JCIH in the USA 
(13). This concept was proposed by the Professional Board of Speech, Language and Hearing 
Professions of the Health Professions Council of South Africa (HPCSA). The guidelines 
propose that (14): 
 all infants should be screened by no later than one month of age, 
 a full audiological examination is offered by three months of age for those infants not 
passing the initial screening test, and 
 infants who are confirmed as having hearing loss should receive appropriate intervention 
by no later than six months of age.  
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The implementation of UNHS requires the National Department of Health to commit both 
economically as well as human resource-wise in terms of adequate staff numbers. Recent 
HPCSA data, acquired via communication with Yvette Daffue from the Information 
Technology (IT) department of HPCSA, shows an increase in the numbers of registered 
audiologists, and this may go some way towards implementing UNHS in South Africa.  
Professor Katijah Khoza-Shangase, Chair of the Education Committee – HPCSA Speech, 
Language and Hearing Board, has commented on the discussions regarding the future training 
of Audiology technicians. This cadre of professionals will occupy mid-level worker positions, 
will be larger in numbers; take a shorter time to train (240 credit programme); and therefore 
increase access to screening services as this will form part of their scope of practice. 
 
 1.2 Justification for this study 
At present there is limited information regarding the current status of neonatal hearing screening 
programmes in South Africa (15). In 2008 (one year after the recommendations from the 
HPCSA regarding EHDI were published),Theunissen and Swanepoel reported  that only 27% 
of public sector hospitals in South Africa were implementing any form of neonatal hearing 
screening (7). A recent national survey of the audiological services in the private health care 
sector of South Africa showed that there is significant delay in the overall diagnosis and 
provision of intervention for hearing loss (16).  
 
 In order to achieve UNHS in all South African hospitals, feasibility studies need to be 
conducted to identify potential shortcomings which will need to be modified before the 
programme is implemented nationally. The results of our feasibility assessment could 
potentially assist future plans for implementation of UNHS. 
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1.3 Study Proposal 
To assess the feasibility of a comprehensive Universal Newborn Hearing Screening programme 
at a secondary level hospital in Johannesburg, South Africa.  
 
1.4 Study Objectives  
Primary objectives:  
1) To determine the number of babies that could be screened for newborn hearing deficits 
during a three month period at Rahima Moosa Mother and Child Hospital (RMMCH) 
with the staff and facilities available during the study period;  
2) To determine the challenges of implementation. 
Secondary objectives: 
1) To determine the number of screened babies with “refer” findings requiring a diagnostic 
hearing assessment, and to determine the rate of true versus false positive results. 
2) To analyse associated risk factors in babies with “refer” findings. 
3) To determine the rate of follow up for babies with “refer” findings. 
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2. Literature Review  
2.1 Prevalence of hearing loss 
Hearing loss has been reported as being the most commonly diagnosed congenital abnormality 
(2). As compared to congenital hypothyroidism, which has an incidence of 50 per 100 000 
infants, there are reportedly 260 per 100 000 infants affected with sensorineural hearing loss 
(4). Globally, there are an estimated 360 million people living with a hearing impairment (17). 
The current reported prevalence of neonatal hearing loss in resource-scarce countries is 6 per 
1000 live births (1) . This is higher than that of resource-rich countries, which have a reported 
prevalence of 2-4 per 1000 (1).  The discrepancy of neonatal hearing loss between regions can 
be attributed to several factors, including resource-scarce countries having a higher incidence 
of infectious diseases such as rubella, cytomegalovirus, measles and HIV; as well as a higher 
rate of premature deliveries (18).  Due to the lack of audiological services and limited screening 
equipment, neonatal hearing losses are typically detected at a later age in children living in 
resource-scarce countries (19). These areas also have the additional burden of HIV, malaria and 
tuberculosis, thereby limiting the available budget of the health care system which can be 
allocated to neonatal hearing screening (12). 
2.2 Definition of hearing loss 
A “disabling hearing impairment” in children under the age of 15 years is defined by the WHO 
as a permanent unaided hearing threshold of 31 dB hearing level or more in the better ear (20). 
According to the HPCSA’s  EHDI position statement, the minimum criterion for screening 
programmes in South Africa is a bilateral permanent hearing loss of at least 40dB across the 
frequencies of 0.5, 1, 2 and 4 kHz (14).  The shortcomings of these definitions are that children 
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with unilateral or milder forms of hearing loss i.e. 20-30dB, are excluded from being identified 
as having a hearing impairment. These individuals are at risk of having language delay, but to a 
lesser degree compared to those with a bilateral hearing loss (1, 5). As per the HPCSA’s 2007 
EHDI, a unilateral pass criterion with Otoacoustic Emissions (OAE) is required to exclude a 
bilateral hearing loss. Congenital or early onset hearing impairments are commonly genetic in 
origin or secondary to a perinatal insult such as congenital infections, birth asphyxia, 
hyperbilirubinemia, or low birth weight (21). 
 
2.3 Effects of undiagnosed hearing loss 
2.3.1. On the individual 
The domains of child development include motor (gross and fine); speech and language; 
cognitive; emotional and personal-social (22). The importance of detecting neonatal hearing 
loss is that significant developmental delay may result in any of these developmental domains, 
but especially in the areas of language and cognition. An expected developmental language 
delay of 2-4 years may occur in a child who only has the hearing loss detected after the age of 
six months of age (3). It is thus imperative that hearing loss is identified early and that 
appropriate intervention occurs in a timely manner. Further consequences of hearing loss in the 
child include possible stigma; social isolation; stress and maltreatment in the form of physical 
or emotional abuse or even neglect (23). Long term consequences may include academic failure 
which could result in career limitations and consequent financial difficulties (1). The income of 
hearing impaired individuals is typically 40-45% less than those without a hearing disability in 
resource-rich countries (24).  
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2.3.2 On society 
The societal burden of supporting a child with a specialised need such as hearing loss broadly 
includes additional financial burdens; specialist educational requirements; professional skills 
burden; and the requirement of ongoing allied medical care (25). The cost of hearing assistive 
devices and specialised schooling can be prohibitive, affecting the entire family, and can result 
in a significant reliance on social services (26). Due to the far reaching consequences of late or 
no detection of hearing impairment, UNHS has been mandated by several resource-rich 
countries.  
 
2.4 Universal Newborn Hearing Screening 
The aim of UNHS is to screen all newborns for a hearing impairment either just after the birthing 
process or before being discharged from the birthing facility (9). The early identification of 
hearing impairments will result in the appropriate intervention being implemented before six 
months of life (9). Early intervention for hearing impairment will result in improved language, 
cognitive and emotional development.  
2.4.1 UNHS in resource-rich countries 
 
UNHS has been embraced by many resource-rich countries as part of their public health 
prevention programme.  Prior to 1993 in the United States of America (USA), only high risk 
infants were assessed for hearing loss and the Auditory Brainstem Response (ABR) was the 
preferred method which was used when conducting the screening test (6). Since the 
recommendation from the National Institute of Health in the USA that all infants should be 
screened within the first three months of life, all 51 states have implemented newborn hearing 
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screening programmes (7). The aims set forward by the American Academy of Pediatrics 
(AAP), according to the 2007 position statement of the JCIH, are that (9): 
 all infants should be screened by no later than one month of age, 
 a full audiological examination is offered by three months of age for those infants not 
passing the initial screening test, and 
 infants who are confirmed as having hearing loss should receive appropriate intervention 
by no later than six months of age.  
UNHS implementation is on the increase globally, as the benefits of early intervention for the 
individual, as well as for society, is undisputed. Of concern however, is the limited 
implementation of UNHS in resource-scarce countries. 
 
2.4.2 UNHS in resource-scarce countries 
At present, the total population from the 164 countries which have been classed as constituting 
the developing world, or resource-scarce regions, is estimated to be five billion people (18). Of 
this total, South Africa – which has been categorised as a resource-scarce country – has an 
estimated population of 54 million people, as per the statistics for the 2015 mid-year population 
estimates (27). There are a diversity of cultures and ethnicities making up this population with 
80.2% being African, 8.8%  Mixed-race, 2.5%  Indian or Asian and 8.4%  Caucasian  (27). 
According to The World Bank, South Africa is classified as an upper middle income country 
(28). However, despite having a relatively good infrastructure, no  UNHS is occurring uniformly 
across all health facilities, including the private healthcare sector (16).   
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Infectious diseases such as HIV, tuberculosis and malaria place a major burden on the health 
care system and available resources in developing countries, and divert funds away from 
screening programmes such as UNHS (26). Other unique challenges encountered by resource-
poor countries  are the differing risk factor profiles such as having a large proportion of neonates 
being delivered in lower care-level facilities of care such as midwife-run obstetric units, which 
have a limited availability of audiological services (21). These factors contribute to the 
inadequate implementation of UNHS in resource-scarce countries. 
 
2.4.3 UNHS in South Africa 
South Africa has made advances towards achieving UNHS by issuing a Hearing Screening 
Position Statement which is based on the Position Statement of the Joint Committee on Infant 
Hearing in the USA. The concept was proposed by the Professional Board of Speech, Language 
and Hearing Professions of the Health Professions Council of South Africa. The guidelines 
recommend that (14): 
- hearing screening is provided to all infants in well-baby nurseries, or upon discharge from 
NICU, or at the primary healthcare clinic when infants receive their immunisations at six weeks 
of age; 
- the diagnosis of a hearing impediment must be made by three months of age, and by the latest 
four months of age, for those newborns who were screened at their primary healthcare clinic; 
- the child should receive some form of appropriate intervention by six months of age, and by 
no later than  eight months of age, when referred by the primary healthcare clinic; 
- ongoing monitoring for a progressive hearing impairment should be continued in those 
individuals who are considered high risk, despite having passed their initial screening test. 
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UNHS is difficult to implement in resource-scarce countries, including South Africa, and a 
targeted approach needs to be applied to detect hearing impairments. This targeted approach 
aims to screen “high-risk” individuals. Although this approach is far from the ideals prescribed 
by resource-rich countries regarding UNHS, it provides a starting point for increasing the 
coverage of infant hearing screening. As resources improve, and awareness and knowledge 
regarding the burden of late detection of hearing loss are better understood, a gradual drive to  
screen all newborns for hearing impediments will hopefully be implemented. 
 
2.5. Risk factors associated with hearing impairment 
Targeted hearing screening is recommended when UNHS is unable to be implemented in 
resource-poor settings. The JCIH (2007) compiled a comprehensive list of aetiologies that may 
be associated with sensorineural hearing loss.  
The JCIH identified the following as risk factors for neonatal hearing impairments, and suggests 
targeted screening in neonates in which the following factors are identified (9): 
1. A permanent childhood hearing loss in the child’s family history. 
2. Any concern from the caregiver regarding the child’s speech and language development. 
3.  A stay of more than five days in the NICU, or any need for assisted ventilation, or 
exposure to ototoxic drugs (aminoglycosides) and loop diuretics, or if there was 
hyperbilirubinemia severe enough to require an exchange transfusion. 
4. Congenital infections especially cytomegalovirus, herpes virus, rubella, syphilis or 
toxoplasmosis. 
5. Craniofacial abnormalities especially those involving the ear and temporal bone. 
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6. Physical features of syndromes associated with hearing loss such as neurofibromatosis, 
osteopetrosis and Usher syndrome - a genetic condition associated with hearing loss and 
a progressive loss of vision (29). 
7. Neurodegenerative disorders such as Hunter’s syndrome - a rare metabolic condition 
resulting in the accumulation of glycosaminoglycans in almost all tissues and organs 
(30). 
8. Culture positive postnatal infections such as bacterial and viral meningitis.  
9. A history of trauma to the head, or a systemic insult such as chemotherapy. 
 
In addition to the above risk factors, maternal HIV and malaria infections are contextualised 
risk factors pertinent to the South African context (8). The current prevalence of HIV in South 
Africa is 6.3 million people as reported in the 2014 UNAIDS Gap Report. Of these 6.3 million 
affected individuals, 3.5 million are females aged 15 years and older (31). Infants born to 
mothers affected by HIV are at a higher risk for premature delivery, low birth weight, and an 
increased susceptibility for other infections which may result in meningitis (10). Maternal 
malaria has been included as a risk factor for congenital sensorineural hearing loss, as the 
treatment of malaria includes drugs that are highly ototoxic (8). 
 
Although a targeted screening such as the one adopted by RMMCH is viewed as a positive step 
toward Early Hearing Detection and Intervention (EHDI), it has been documented to have 
significant flaws. Studies have shown that by screening only those infants considered “high-
risk” approximately 50% of infants with hearing impediments would be missed (6). Thus, 
increased effort is warranted to ensure that every neonate is screened for hearing impairment. 
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2.6 Hearing impairments and current testing equipment 
In order to implement a successful screening programme, objective physiological measures need 
to be utilized so that the results are interpreted correctly. At present, the two standard methods 
utilised in neonatal auditory screening are Automated Auditory Brainstem Response (AABR) 
and the Otoacoustic Emissions (OAE) measures (32).   
 
2.6.1. Otoacoustic Emissions (OAE) 
OAEs are low energy sound waves which are produced by movement of the hair cells of the 
cochlea in response to a sound stimulus (33). These sound waves can be measured by a probe 
that is placed at the external auditory canal, provided there is a healthy, functioning middle ear 
and outer ear canal (33). The OAEs are a measure of the functional integrity of the cochlea’s 
response to sound, and thus a good measure of the peripheral auditory system (33).  
 
There are two types of OAE measurements: distortion-product otoacoustic emissions OAEs 
(DPOAE) and transient evoked otoacoustic emissions (TEOAEs). DPOAEs are produced by 
combining two tones of different frequencies and then measuring the response produced by the 
cochlear, at a third frequency, by placing a probe in the external auditory meatus (34). TEOAEs 
are produced by the hair cells of the cochlea in response to a series of clicks or tone-burst stimuli 
of short duration, across the frequency range of 500-4000 Hz (34). Both DPOAE and TPOAE 
have been used in newborn hearing screening. DPOAE has the advantage over TEOAE in that 
it is better at detecting emissions with a frequency of more than 5000 Hz (18). High frequency 
loss patterns are associated with ototoxicity and noise-induced hearing loss (35, 36). 
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There are many benefits of using OAE testing as a screening tool, namely: the test provides 
objective evidence of peripheral auditory integrity; it is relatively quick to perform; it is reliable; 
the procedure can be performed by non-audiologists, an important advantage in resource-
constrained environments such as South Africa; and it does not require sedation or co-operation 
on the part of the patient (37). The major disadvantage of the OAE is that it does not assess the 
integrity of the auditory nerve (33). This is a significant shortcoming of OAEs testing as an 
individual with a hearing impairment resulting from an auditory neuropathy would be able to 
pass the hearing screening with an OAE and thus not be identified for further intervention. 
 
The OAE may also be negatively affected by middle ear pathology such as otitis media, 
perforated tympanic membrane or otosclerosis, as well as by the presence of any debris in the 
outer ear canal such as vernix caseosa or cerumen (37). Environmental noise may also interfere 
with the reliability of the OAE (33). Presence of debris in the outer ear canal has been shown to 
increase the number of false positives during UNHS prior to hospital discharge; and so it is an 
important consideration during implementation of any UNHS initiatives (38).   
 
2.6.2. Automated Auditory Brainstem Response (AABR) 
The AABR is an electrophysiological response to an acoustic stimulus that is delivered via an 
earphone (39). Surface electrodes placed on the scalp record the neural activity generated in the 
cochlea, auditory nerve and brainstem and AABR’s are therefore able to provide more 
information with regards to an auditory neuropathy. The AABR results are less likely to be 
affected by outer and middle ear conditions (39). The AABR as a screening tool is safe, 
acceptable, reliable and valid, but the AABR has a higher fail rate when it is used in testing 
areas with high ambient noise levels, and when inexperienced staff perform the testing 
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procedure (39). AABR is recommended as the screening ideal for neonates who are particularly 
at risk for an auditory neuropathy – as are neonates who required NICU admission (40). 
Neonates admitted in the NICU typically have several risk factors present such as prematurity 
with low birth weight, or the presence of systemic infections, therefore rendering them more 
susceptible to an auditory neuropathy (40, 41).  
 
2.6.3 Tympanometry 
Tympanometry is required at secondary and tertiary hospitals, to distinguish between a middle 
ear infection and a sensorineural hearing loss resulting in a refer result on the OAE (37). A high 
frequency 1000Hz probe is placed in the ear and the results are used to refer appropriately for 
either medical management of a middle ear infection or for further audiological investigations. 
 
2.7 Benchmarks and quality indicators for UNHS 
Certain criteria need to be enforced to maintain a suitable standard of UNHS and to ensure 
optimal inter-programme comparison. The quality indicators set out by the HPCSA for hospital-
based screening include (14): 
- with regards to universality, 95% of infants should be screened by the time of discharge 
or by one month of age, 
- after the first year of the UNHS programme being implemented, the referral rate for 
audiological evaluation should ideally be less than 5%, 
- a follow-up rate of more than 70%.  
A systematic review by Mincarone et al. showed that there is poor standardization of UNHS 
reporting and screening protocols and they propose that this can be improved with the use of a 
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checklist (42). The reference indicators include universality, timely detection and over-referral. 
In order to improve the quality of the services offered, regular monitoring of these indicators is 
required.  
 
2.8 Implementation of UNHS in South Africa 
In order for UNHS to be successfully implemented in South Africa, several factors need to be 
considered. 
 
2.8.1. The availability of local resources  
The estimated population of South Africa is 54 million as at July 2015 according to Statistics 
SA (27). The number of live births in 2014 was 1 207711. If UNHS was fully implemented, all 
of these newborns would have required screening. The teams of professionals who have 
historically been responsible for the hearing screening are the speech therapists and audiologists. 
According to the National Treasury Department of South Africa, the number of speech and 
hearing therapists increased from 239 in 2003/04 to 363 in 2008/09 (43). This was an increase 
of 124 speech and hearing specialists in a five year period. This very minimal growth in the field 
of audiology is also demonstrated by recent data acquired from the IT department of HPCSA 
via email communication, which states that as from the 31 December 2015, there are 497 
registered audiologists; 925 speech therapists, and a further 1510 therapists registered for both 
speech therapy and audiology. This results in a total of 2932 registered therapists who are 
qualified to screen and manage hearing impairments in South Africa. The documented increases 
in numbers do not correlate with the demand for the audiological services in the country; 
therefore UNHS has not as yet been successfully implemented. 
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2.8.2 Screening contexts 
The HPCSA’s 2007 EHDI position statement recommends that hearing screening should occur 
at one of three possible time points: the well-baby nursery shortly after birth, the Primary Health 
Care clinic when the infant is 6 weeks of age and requiring immunisations, or at discharge from 
NICU (14). A fourth feasible context for screening, as recommended by Khoza-Shangase et. al. 
is the Midwife Obstetric Unit (MOU) at the three-day neonatal follow-up visit. This study 
showed that a higher proportion of neonates were screened on day three of life (100%) compared 
to only 38.1% of those being screened hours after birth (44). 
 
2.9 Conclusion 
Hearing loss is the most common congenital condition. The undisputed benefits of early 
identification and referral for suitable audiological intervention warrant the application of a 
UNHS service to the South African population; hence the importance of the current study which 
aimed at assessing feasibility of a Universal Newborn Hearing Screening Programme at Rahima 
Moosa Hospital, in Johannesburg, South Africa.   
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3. Methods 
3.1 Study design 
We conducted a prospective feasibility assessment. A feasibility study is one in which various 
parameters are evaluated prior to implementing the main study. These parameters may include 
the readiness of physicians to enroll patients; follow-up rates; the time required to perform the 
test; the number of appropriate participants and the evaluation of the outcome measures. 
Feasibility studies are typically used in assessing screening programmes to see if they can be 
implemented at a population level (45). 
3.2 Study setting 
The study was conducted at RMMCH, an academic secondary level hospital in Johannesburg, 
South Africa. In order to provide a realistic assessment of the feasibility of implementing UNHS 
at this institute, only the existing staff and equipment were utilized. 
3.3 Study population and sample 
The study population was drawn from all neonates born at RMMCH using stratified systematic 
sampling. Selected neonates from the postnatal wards, the neonatal unit and NICU were 
assessed. The postnatal wards accommodate healthy babies born via caesarean section or normal 
vaginal delivery. The neonatal unit cares for neonates born prematurely with birth weights 
<1800g; neonates with infections; neonates with perinatal asphyxia; and neonates with jaundice. 
Neonates admitted to NICU, mostly display complications of prematurity or neonatal 
encephalopathy.  
 19 
 
The delivery rate at RMMCH is currently approximately 20-30 neonates per day. This number 
was too large for the current audiology team to assess, so a representative sample was taken. A 
total of 10 neonates was considered to be a realistic number to be screened by one audiologist 
daily. To avoid enrolling a biased sample, every third neonate appearing on the birth registries 
in the labour ward and in the Caesar theatre was added to the list of potential neonates to be 
screened if they met eligibility criteria. The sample was stratified to be representative of the 
hospital’s current Caesarean section rate of 30%, by selecting 30% of the neonates to be tested 
from the Caesar theatre birth register and the remaining 70% from the labour ward registry. A 
total of 10 neonates were identified every day. This stratified, systematic sampling was done at 
the start of each weekday by the researcher. 
Inclusion criteria 
 All neonates born at RMMCH between the 01 January 2012 and 31 March 2012. 
 At the time of screening, infants were to be younger than thirty days of chronological 
age. 
 
Exclusion criteria 
 Neonates not born at RMMCH and transferred in from other facilities. 
 Any neonate whose parent/caregiver refused to provide informed consent. 
 Neonates who spent more than a month in NICU were excluded as they would have 
exceeded the age cut-off of one month. 
3.4 Study procedure 
3.4.1 Identification and enrolment 
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Auditory screening assessments took place during weekday working hours and were conducted 
by the hospital’s audiologists during the defined three month period.  Healthy neonates were 
screened within the first few days of life, while neonates with complications preventing earlier 
screening were screened when possible within the first 30 days of life. The screening team 
consisted of four qualified audiologists. One audiologist was assigned to carry out the screening 
tests each week, on a rotational basis. No additional staff were employed to assist in the 
screening of these neonates, and the screening of the neonates was to be factored into their 
already busy schedules of ward and clinic responsibilities. 
Neonates were selected from the birth registries in labour ward and Caesar theatre as per the 
stratified systematic sampling described above. A total of ten neonates were selected daily by 
the researcher; three from the Caesar theatre registry and seven from the labour ward registry. 
Each of these pre-identified neonates was assigned a study number by the researcher and the list 
of neonates requiring testing was given to the allocated audiologist. As this was a feasibility 
study, the audiologist would perform testing on as many babies as possible from the list. The 
audiologist would commence screening in numerical order as per the list of identified neonates. 
In the event that the audiologist was unable to locate a patient who may have been discharged 
or if the caregiver refused screening, the audiologist would proceed to the next neonate 
numerically on the list. The study protocol was explained to one or both parents and they were 
provided with an information sheet containing pertinent information about the testing (Appendix 
A).  Written informed consent was obtained prior to testing (Appendix B). This informed 
consent was only obtained immediately prior to the screening, so that there would be no 
possibility of a caregiver consenting to the screening and the neonate not being assessed due to 
time constraints or equipment malfunction. The neonates’ clinical history was obtained in all 
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cases prior to testing. This was obtained both verbally from the parent and by obtaining 
information documented in the neonate’s hospital file. Testing was initially conducted in a side 
room outside the postnatal ward, but due to noise interference was later moved to the audiology 
department. For those neonates who had been admitted to the neonatal unit, screening was 
carried out in the neonatal ward. Neonates admitted to NICU were screened only after being 
discharged from NICU as the high ambient noise levels would have interfered with the screening 
process. 
3.4.2 Measurements 
Each neonate who was screened first underwent an otoscopic examination, performed by the 
audiologist, to assess patency of the ear canal as this could potentially impede the screening 
procedure and impact the result. Thereafter, Distortion Product Otoacoustic Emission (DPOAE) 
testing was conducted on both ears, giving either a “pass” or “refer” result. The machine used 
was a Natus Bio-logic AuDX® (Appendix C). 
 A “pass” result was obtained if the patient passed the DPOAE test across three or more 
of the five tested frequencies (1000kHz, 2000kHz, 3000kHz, 4000kHz and 5000kHz) at 
25-30 decibels hearing level, in both ears. 
 A “refer” result implies that the patient did not pass the hearing screening test across 
three or more of the five tested frequencies (1000kHz, 2000kHz, 3000kHz, 4000kHz 
and 5000kHz) at 25-30 decibels hearing level, in both ears. A “refer” result could be the 
result of an actual hearing deficit, or due to noise interference. 
The staff member conducting the screening test would record the results of the test; indicate 
the time taken to screen the neonate; what the challenges had been encountered during the 
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testing process; and what the plan of action would be (See data capture sheet, Appendix D). 
Babies receiving a “pass” result were discharged without a planned follow-up, unless follow-
up was clinically indicated. Newborns receiving a “refer” result were rescreened within a 
month of initial screening. The re-screening procedures included an otoscopic examination, 
a tympanogram, and a repeat DPOAE. The tympanogram was only performed on babies who 
had not passed the initial screening test, as the equipment was located in the Speech and 
Hearing Department and neonates were required to attend the department for testing. 
Neonates who were too ill to leave the ward were thus unable to be tested for a tympanogram. 
The tympanogram would possibly provide helpful information pertaining to conduction 
deficits in those who had referred on the initial DPOAE. If the results of the re-screening 
procedures were still inconclusive, the infant was referred for diagnostic ABR performed at 
Charlotte Maxeke Johannesburg Academic Hospital (CMJAH).  
   3.4.3 Study data sheet 
A study data sheet was completed by the staff member for each neonate that was screened 
(Appendix D). Information on this form was verified by the researcher, by retrieving 
information from the hospital file and from asking the caregiver questions. The study data sheet 
comprised three sections which included general information of the baby; the presence of risk 
factors; and the findings on clinical assessment. 
 General information provided information regarding the demographics of the babies 
being screened and included: 
- type of delivery, 
- birth weight, 
 23 
 
- HIV exposure,  
- Apgar scores,  
- ward where the neonate was located.   
 A risk factor assessment was completed for each neonate screened. The following 
items were included: 
- a family history of permanent childhood hearing loss, 
- admission to NICU, and if so, was assisted ventilation required, 
- exposure to ototoxic drugs such as such as aminoglycosides or loop diuretics, 
- hyperbilirubinemia requiring exchange transfusion,  
- congenital infections such as: cytomegalovirus, herpes, toxoplasmosis, 
rubella, syphilis, HIV and malaria ,  
- the presence of craniofacial abnormalities.  
 Examination Findings 
The data sheet captured information from the initial screening as well as the re-screening 
procedure, if this was required.  
- Otoscopic examination was vital to provide information regarding the presence or 
absence of vernix, or if there were anatomical defects present such as a narrow ear 
canal. Additional information pertaining to the otoscopic examination could be 
indicated. 
- Data indicating which frequencies, ranging from 1000 kHz-5000 kHz, had been 
tested and passed, as well as the duration taken to complete testing, were captured. 
- In addition, data indicating the challenges perceived by the screening team that may 
have resulted in “refer” results were also captured. 
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3.5 Statistical analysis 
Data was entered into Microsoft Office Excel ©, and later analysed using STATA I/C version 
11© (46). Numerical data was described in terms of median, and interquartile range. The 
outcome variables were the total number of neonates screened, and the number of those screened 
who received a pass or refer result. Chi square tests were used to identify associations between 
risk factors and unsuccessful hearing assessments. Odds ratios with 95% confidence intervals 
were used to quantify significant associations. P-values less than 0.05 were considered 
statistically significant (47).  
 
 
3.6 Ethical considerations 
The study adhered to the Singapore Statement on Research Integrity guidelines in terms of 
research into human subjects (48). Therefore, ethical approval to conduct this research trial was 
obtained from the Committee for Research in Human Subjects at the University of 
Witwatersrand (Medical). HREC number M111119 (Appendix E). 
Informed consent was signed by the parents or legal guardians of all participants enrolled onto 
the trial. Access to the Excel database was limited to the researcher. 
All neonates screened were assigned a unique study identification number to ensure 
confidentiality. This number was assigned to the individual on the day of the initial screening 
and was the only form of identification used if the baby was brought back for repeat DPOAE. 
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Appropriate counselling and referral would be provided to the caregivers of a baby found to 
have a hearing impairment. 
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4. Results 
4.1 Study Population 
During the study period, 2740 neonates were born at RMMCH. A total of 490 neonates were 
identified and assigned study numbers during the three month period over which the study was 
conducted. Of the sample group, two mothers refused consent for their infants to be screened. 
One hundred and twenty one neonates were screened, representing 24% of the identified 
neonates. A total of 369 neonates (75.3%), were identified for potential screening but did not 
receive a hearing assessment. Thus, of the 2740 neonates born at RMMCH during the three 
month study period, 4.4% underwent screening.  
Eight (7%) of the 121 neonates that were screened were assessed in the neonatal unit whilst the 
remainder (n=113, 93.4%) were screened in the postnatal wards. Seventy-nine (65.3%) neonates 
were born via normal vaginal delivery, with two (1.7%) requiring assisted delivery, and 40 
(33%) were born via caesarean section. This distribution of delivery patterns was in accordance 
with the hospital’s anticipated caesarean section rate of 30%. During the three month screening 
period there were 855 caesarean section deliveries, making up 31.2% of the total deliveries. Of 
the 121 study participants screened, 90 (74.4%) were HIV unexposed, 29 (24%) HIV exposed, 
and two (1.6%) were born to mothers who had, at the time of screening, not yet been tested for 
HIV. These sample population demographics are depicted in Table 4.1.  
 
 
 
 27 
 
Table 4.1 Sample population demographics 
 Neonates screened (N=121) 
Birth weight (gram) n (%) 
<2500g 
≥2500g 
 
16 (13.2%) 
105 (86.8%) 
Type of delivery n (%) 
NVD 
Caesarean section 
Assisted delivery 
 
79 (65.3%) 
40 (33%) 
2 (1.7%) 
HIV exposure n (%) 
Yes 
No  
Unknown HIV status 
 
29 (24%) 
90 (74.4%) 
2 (1.6%) 
ICU admission after birth n (%) 
Yes 
No 
 
2 (1.7%) 
119 (98.3%) 
APGAR Scores 
1 minute Apgar ≤5 
1 minute Apgar >5 
 
5 minute Apgar ≤5 
5 minute Apgar >5 
 
10 minute Apgar ≤5 
10 minute Apgar >5 
 
6 (5%) 
115 (95%) 
 
0 
121 (100%) 
 
0 
121 (100%) 
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Birth weights ranged from 1700g to 4080g with a median of 2915g, as depicted in Figure 4.1. 
 
Figure 4.1 Distribution of birth weights 
Ninety one (75.2%) of the 121 neonates were screened in the first 24 hours of life. A further 21 
(17.4%) were screened at 24-48 hours of life, and seven (5.8%) were screened at 48-72 hours 
of life. The remaining two (1.6%) were screened on day seven of life. 
 
4.2 Screening results 
Fifty-seven of the 121 participants (47.1%) had a refer result at the first screening, whilst the 
remainder were discharged from the program because they passed the screening bilaterally. Of 
the 57 due to come back for repeat DPOAE, only 20 (35.1%) returned for follow-up. Upon 
repeat DPOAE, 18 of the 20 (90%) passed and therefore were subsequently discharged and two 
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(10%) required ABR as per research protocol. Of the neonates requiring ABR, one neonate was 
a term baby, born vaginally, with a birth weight of 3.27 kg, and had no associated risk factors. 
On the initial screening test, the audiologist indicated that noise and vernix caseosa contributed 
towards the challenges experienced. At the repeat DPOAE, the otoscopic examination was 
normal and the challenge faced was that the baby had been crying during the second assessment. 
The caregiver did not return with the infant for the third follow-up.  
The second neonate who referred on two DPOAEs was a low birth weight infant of 2.48 kg, 
who was delivered by vacuum delivery, and had no associated risk factors. Vernix caseosa and 
noise were identified as challenges experienced during the initial screening. This neonate did 
not pass the repeat DPOAE and, as per our protocol, should have been referred to CMJAH for 
an ABR. However, at the time of our study the ABR machine at the CMJAH was not functional 
and hence this neonate underwent a third DPOAE, which was successfully passed.  
Ultimately only 83 neonates were successfully screened, as 38 individuals were lost to follow-
up. Figure 4.2 depicts the outcomes of the screening process in a flow diagram. 
 
 
 
 
 
 
 30 
 
 
Neonates identified 
N=490 
 
Screened, N=121 (24.7%) 
 
Requiring repeat DPOAE, N=57 (47.1%)              Passed screening test, N=64 (52.9%) 
 
Returned for repeat DPOAE, N=20 (35.1%)               Lost to follow-up, N=37 (64.9%) 
 
Requiring ABR, N=2 (10%)                             Passed second DPOAE, N=18 (90%) 
 
             Passed third DPOAE, N=1 (50%)               Lost to follow-up, N=1 (50%) 
 
 
Figure 4.2 Flow diagram showing the screening outcomes 
 
4.3 Risk factor assessment 
The assessment of the presence of risk factors showed that 2 of the 121 neonates screened (1.7%) 
had been admitted to NICU, and both babies required assisted ventilation. The first neonate had 
an NICU stay of six days and passed the initial DPOAE which was conducted on day 7 of life. 
The second neonate was admitted to NICU for eight days and was considered high risk for a 
possible hearing deficit as several risk factors were identified, namely: 
 
Not screened, N 
=369 (75.3%) 
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- a positive family history (the maternal uncle) of permanent childhood hearing loss  
- the presence of a congenital syphilis infection 
- requiring intermittent positive pressure ventilation in NICU for six days 
- postnatal exposure to aminoglycoside antibiotics.  
In this neonate, the initial DPOAE result was that of a bilateral ‘refer’, but upon retesting after 
discharge from NICU, the results were a bilateral ‘pass’.                                                                                     
Other risk factors identified in the screened population, included a family history of hearing loss 
recorded in ten (8.3%) neonates. Four of the neonates with a positive family history had a refer 
result on their initial DPOAE and the caregivers were requested to return for follow-up testing. 
Only one infant was brought back for a second DPOAE, which was passed successfully, and 
the remaining three infants were lost to follow-up.  
Exposure to ototoxic medications in the form of aminoglycosides was recorded in three neonates 
in the screened cohort (2.5%). One of these neonates with ototoxic drug exposure required a 
repeat DPOAE, which was successfully passed.  
One neonate born at full term with a birthweight of 2.8kg had a raised bilirubin level of 332 
umol/l at 72 hours of life. According to the NICE guidelines for neonatal jaundice,  phototherapy 
was all that was required as the management (49). Although the initial DPOAE generated a 
‘refer’ result, the infant passed the repeat DPOAE.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
No neonates in the screened cohort presented with craniofacial abnormalities.  
Table 4.2 displays the risk factors according to the two groups – those that passed the initial 
DPOAE (n=64) and those requiring a repeat test (n=57). 
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Table 4.2 Outcome groups on initial DPOAE screening and recorded risk factors 
 ‘Passed’ screening test 
N=64 
Requiring repeat 
DPOAE, N=57 
Total screened 
N=121 
Admitted to NICU 
n(%) 
1 (1.5%) 1 (1.7%) 2 (1.6%) 
Family history of 
permanent hearing loss 
n (%) 
 
6 (9.3%) 
4 (7%) 10 (8.2%) 
Exposure to ototoxic 
drugs 
n (%) 
2 (3.1%) 1 (1.7%) 3 (2.4%) 
Hyperbilirubinemia 
n (%)  
0 (0%) 1 (1.7%) 1 (0.8%) 
Congenital infection 
n (%) 
0 (0%) 1 (1.7%) 1 (0.8%) 
 
Risk factors were not significantly associated with referring on or passing the DPOAE. 
4.4 Otoscopic examination results 
Otoscopic examinations revealed that 86 (71.1%) neonates had vernix caseosa in their external 
auditory canal, and 39 (32.2%) were subjectively considered to have narrow ear canals. Other 
findings included: the presence of blood in the right ear canal (n= 1), a pre-auricular skin tag 
(n= 1), and an ear canal that collapsed during testing (n= 1). 
Of the 86 neonates identified with vernix caseosa in the auditory canal, 50 (89.3%) required a 
repeat DPOAE compared with seven of the 35 neonates (20%) who did not have the substance 
in the external auditory canal (OR: 4.0, 95% CI: 1.75-9.16, p= 0.0001). 
The occurrence of a narrow ear canal was a subjective finding identified on otoscopic 
examination by the audiologist in 39 cases; 18 (46.2%) of which required a repeat DPOAE 
versus 39 (47.6%) of those without a narrow canal (OR: 0.86, 95%CI: 0.46-1.61, p= 0.88). 
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4.5 Challenges identified by the assessor during the screening procedure 
The audiologists conducting the testing recorded challenges encountered which made the 
screening process more difficult. These challenges did not necessarily result in a refer result, 
but were any factors that may have contributed towards a prolonged testing time. The assessors 
documented their starting time when commencing the screening and upon completion would 
again document the time; therefore giving a record of the time required to screen each newborn.  
The mean time taken to screen each neonate was 11 minutes 17 seconds, with the longest 
duration being 40 minutes and the shortest screening time being 5 minutes. The median time 
taken to screen was 10 minutes. Thirty four neonates had a screening time of longer than 11 
minutes, and 11 (32%) of these neonates had no identifiable challenges contributing towards 
their prolonged testing time.  
Challenges included equipment failure, noise interference, and vernix caseosa in the external 
auditory canal.  
 Equipment failure was identified as a challenge by the assessors in five (4.1%) cases, 
two of which required repeat DPOAE. Only one patient requiring repeat testing returned 
and subsequently passed the DPOAE.  
 Noise interference was identified in 39 (32. 2%) cases and 27 (69.2%) of these required 
a repeat DPOAE (OR: 2.25, 95%CI 1.14-4.44, p= 0.001).  Half of these children, (14/27, 
52%) also had a finding of vernix caseosa in their ears. 
  Vernix caseosa was identified by the audiologists as a challenge in 40 (33.1%) neonates, 
with 39 (97.5%) neonates requiring a repeat DPOAE (OR: 0.015, 95%CI: 0.002-0.1155, 
p< 0.0001). The presence of vernix caseosa was documented as an examination finding 
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in 86 (71%) infants, but was identified as a challenge complicating testing in only 40 
(33%) infants. 
 Other challenges identified included crying (n=4, 3.3%), the screening session being 
interrupted (n=1, 0.8%), and a baby that was hiccupping during the testing procedure 
(n=1, 0.8%).  
These challenges, as well as the initial screening results are depicted in Table 4.2. 
Table 4.3 DPOAE screening test results for the cohort of 121 neonates 
Initial test result, n (%) 
Pass 
Refer 
 
64 (53%) 
57 (47%) 
Difficulties encountered during testing, n (%) 
Vernix 
Noise interference 
Equipment 
 
40 (33%) 
39 (32%) 
 5 (4.1%) 
 
 
4.6 Other challenges identified during the study 
 During the three month testing period, 121 neonates out of a total of 2740 live birth deliveries 
(4.4%) were screened. Several challenges were encountered during the testing period:  
 High patient-assessor ratio – a team of four audiologists were available to conduct all 
the screening tests. However, one of the audiologists resigned during the study period 
and the diminished team was unable to test all the newborns. Prior to the decrease in the 
staff complement, the audiologist on duty would see, on average 12 neonates per week. 
This decreased in the third month of testing, to 7 neonates per week (Figure 4.3). 
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 Technical difficulties were encountered with the OAE machine in the second week of 
screening, and the machine was sent in for repairs. The repair process took three weeks 
to complete. Only one neonate was screened during this period and screening could only 
recommence once an OAE machine had been loaned from the Wits audiology 
department in the fourth week of testing.  Another technical difficulty encountered was 
that at the time of the screening, the ABR machine at CMJAH was also being repaired. 
This resulted in the two neonates who should have had an ABR after not passing the 
DPOAE on two occasions, requiring a third DPOAE. 
  
 
Figure 4.3 Bar diagram indicating the number of neonates screened per week and the number 
of ‘refers’ per week 
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5.0 Discussion 
The study results will be discussed in this section. Challenges encountered will be described, 
and recommendations for clinical practice will be made. 
This study highlighted many of the challenges present in our setting that are preventing the 
implementation of UNHS. A comprehensive set of standards has been stipulated by the JCIH 
(2007) for evaluating the efficacy of EHDI. These benchmarks  include (9): 
 A minimum of 95% of all neonates are screened by one month of age, 
 The referral rate of those not passing their initial screening test should be less than 4%. 
The return rate of those who require further diagnostic evaluation after failing the initial 
screening, should be at least 95%,  
 By three months of age, 90% of infants who failed the screening tests should have a 
thorough diagnostic evaluation. Infants with confirmed hearing loss should receive 
amplification, if the family elects to amplify, within a month of confirmed diagnosis. 
These benchmarks of quality for UNHS are difficult to achieve in developing countries (12). 
5.1. Main findings 
The implementation of a UNHS programme at RMMCH, a secondary institute, is not attainable 
in the current setting with the available staff and equipment.  The primary objective of this study 
was to assess the number of newborns that could be screened in a three month period at 
RMMCH utilising the currently available staff, equipment, and facilities. Determining the 
number of neonates who could be screened during this feasibility assessment enabled us to 
assess if a UNHS programme could be successfully implemented at RMMCH and what 
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challenges would need to be addressed prior to the initiation of the programme. During the 
specified study period, 2740 neonates were born at the facility and only a very small number of 
them – 121 (4.4%) had an initial DPOAE. The final number of neonates who were successfully 
screened was only 83 in total (3%), as 38 neonates were lost to follow up prior to receiving a 
final result.   
When the study was initiated we had anticipated screening ten neonates a day through a five 
day work week, for a continuous three month period. However, at the end of the study period, 
490 neonates had been identified for screening, with only 83 neonates having been screened. 
This was significantly less than what we had anticipated. Several factors which contributed to 
this poor screening coverage included factors that prolonged the screening time such as vernix, 
high ambient noise levels and equipment failure. Other factors included the high ‘refer’ rate and 
inadequate number of screening staff. Our primary objective was to assess the number of 
neonates that could be screened at RMMCH in a three month period. With only 3 % of identified 
neonates being screened, leads one to presume that UNHS, cannot as yet, be successfully 
implanted in this setting, and that targeted screening should be considered. 
Targeted screening for hearing loss is an option which needs to be considered in settings in 
which adequate screening numbers cannot be attained.  The American Joint Committee on 
Infant Hearing has recommended targeted newborn hearing screening, in resource-scarce 
countries, for infants considered to be at high risk of hearing loss (9). This may be acceptable 
as an interim measure, but it has been reported that targeted screening misses up to 50% of 
infants with hearing impairments, therefore this is a poor alternative (50).  
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The role of UNHS is to detect hearing impairment and provide intervention for children 
requiring hearing amplification before the major speech and language milestones have been 
missed. Children with a disability – like hearing loss – in a resource-scarce country, are at high 
risk of experiencing malnutrition and physical abuse (23). Access to social services is also 
limited. The detection of a disability is a priority, especially if intervention is available (50). The 
other issue with such targeted screening is that the targeted screening programmes whose risk 
factors have been stipulated by the JCIH – an organisation based in a resource-rich nation – may 
not identify risk factors which are prevalent in resource-scarce countries e.g. infectious diseases,  
non-elective caesarean delivery, maternal hypertension and malnutrition (21). Research 
determining risk factors which are more relevant for targeted screening in a developing country 
is needed. The WHO Report on Newborn and Infant Hearing Screening recommends UNHS, 
utilising either OAE or ABR, be the goal of both developed and developing countries (5).  
5.2 Challenges encountered during screening 
Several challenges were identified by the professionals conducting the screening tests. Identified 
challenges will be discussed. 
5.2.1 Staff 
The primary challenge encountered in our study was the limited, although enthusiastic, number 
of audiologists available to perform the screening tests. The team was initially comprised of 
four audiologists, three of whom held senior positions within the department and one who was 
completing her community service year. During the second month of screening, one of the 
audiologists resigned, thus reducing the team to only three. The audiologists worked according 
to a pre-planned schedule as to who was assigned to conduct the weekly screening tests, but 
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with their team being reduced by 25% they needed to redistribute their resources so as to cover 
all of their clinic as well as ward duties. With 2740 neonates being delivered during the three 
month screening period, 228 neonates would need to be screened per week, and 45 neonates 
would require screening daily during a five-day work week. Audiologists employed in the state 
sector, do not currently receive financial remuneration for any overtime work and so screening 
had to take place during regular working hours. A greater number of audiologists and/or speech 
therapists would be required to meet screening targets successfully as therapists need to see to 
other work commitments on a daily basis.  An alternative to these professionals being solely 
responsible for carrying out the screening tests would be to involve the nursing staff. This would 
alleviate the problem of the audiologists being required to conduct screening afterhours as most 
nursing staff work in shifts and so would be available for afterhours testing. In Lagos Nigeria, 
a two week training period for non-specialist staff in the use of TEOAE screening was deemed 
feasible. The study reported that 98.7% of all eligible newborns were screened  before being 
discharged from the hospital (51). A similar study was conducted in South Africa, where clinic 
nurses were trained to screen infants, attending their primary health care clinics, with DPOAE. 
Although this community-based infant hearing screening program was successful in achieving 
a high follow-up rate for those requiring repeat testing, it only managed to screen 32.4% of 
infants eligible for screening (52).  
5.2.2 Equipment 
Our testing equipment – the OAE machine – was another challenge encountered which 
contributed towards the limited number of neonates being screened. In the second week of 
screening, the OAE machine malfunctioned and was sent to the manufacturer for repair. The 
repair of the occluded probe tip, took three weeks to complete. We were without an OAE 
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machine for 2 weeks, during which no neonates were screened. However an identical model 
OAE machine was loaned to us from the Wits Audiology department and screening could 
resume using the loaned machine. This technical complication was unexpected, but highlights 
the fact that in order for a unit to have a successful UNHS programme, there should be two 
machines available so that screening is not interrupted should there be a fault with one of the 
machines. There were no further equipment failures during the study, however in five cases the 
screener felt that the equipment was contributing to the refer result. Of these five cases, two 
neonates required a repeat OAE with one of the neonates passing on the second attempt and the 
other being lost to follow-up. 
Another challenge encountered was that in our protocol we had indicated that if a neonate had 
received a refer result on two occasions the next step would be to have an ABR carried out at 
CMJAH. Of the 20 babies that returned for repeat OAE, two required an ABR, however, at that 
time the ABR machine at CMJAH was undergoing repairs. This resulted in one infant having a 
third OAE which was successfully passed, and the other infant was lost to follow-up. 
Technical issues encountered with both the OAE machine and the ABR equipment were major 
challenges impacting on the successful implementation of our study. Although these 
physiological forms of testing are the approved screening methods, alternative methods may be 
utilised  in resource-poor settings (5, 14). Behavioral Observation Testing was shown to have a 
high sensitivity and specificity as well as being quick and inexpensive to perform; although its 
specificity and sensitivity has been found lacking when compared to objective 
electrophysiologic measures (53). This method involves observing the infant’s behavioural 
response to a sound stimulus. Historically, this form of testing was associated with infants aged 
six to nine months, which may be too late considering the 2007 JCIH guidelines on detecting 
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hearing impairments recommend that hearing loss be identified by three months of age (32). 
Behavioural observation testing could be of limited use in the interim for developing countries. 
5.2.3 Noise levels 
Ambient noise level was another challenge that was encountered. We had initially arranged for 
all the neonates in the postnatal wards be screened in a side room just outside of the ward. The 
room is off a passage connecting the two postnatal wards and we did not anticipate this passage 
being so noisy. After the first week of testing, we decided to move the area for screening to the 
speech therapy department. This change in location for screening meant that all neonates needed 
to be transported in their cribs from the second floor postnatal ward to the third floor speech 
therapy department, and the mothers needed to be ambulant to accompany their neonates. This 
resulted in neonates born via caesarean section only being able to be screened on day two of 
life, once their mothers had been discharged from the ward and were ambulant.  
High ambient noise levels were identified by the audiologists as being a noteworthy challenge 
and resulted in a statistically significant number of children requiring a repeat DPOAE. The 
ideal hospital ward should be a setting of rest for a patient, especially in a postnatal ward where 
mothers and babies are rooming-in together. The reality is that the ambient noise levels typically 
range between 61.0-90.5 dB in a hospital setting (54). According to the World Health 
Organization, an ideal ambient noise level in a hospital ward is 30dB (55). A dedicated testing 
area with ambient noise levels not exceeding 50-55dB is required so as to minimize the number 
of false positive test results (56). False positive “refer” results may cause the caregivers undue 
stress and result in the caregivers having to return to the hospital for a repeat screening test. 
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5.2.4 Vernix caseosa 
 Vernix caseosa is a physiological substance produced by the foetus in utero and consists of 
water (81%), lipids (9%) and proteins (10%) (57). The vernix caseosa has several functions, 
most importantly; it acts as an epidermal barrier in utero. Despite the high water content of 
vernix, it has a high viscosity as the water is thought to be contained within the corneocytes of 
the foetal skin (57). Due to the sticky nature of vernix, it can be quite difficult to remove from 
a neonate’s ear. Vernix caseosa was identified as a significant challenge in the assessment of 
hearing in our study. Otoscopic examination revealed 86 (71%) neonates having vernix in their 
ears, but in only 40 (46%) was this identified as a challenge by the screener. Forty five percent 
of neonates with vernix caseosa present in the external auditory canal required repeat DPOAE. 
The presence of vernix caseosa was a statistically significant finding and, in an ideal testing 
scenario, time should be taken to try and remove the vernix caseosa prior to conducting the 
DPOAE. The removal of vernix caseosa and other debris in the ear canal of neonates has been 
shown to improve the pass rates when conducting OAEs (58, 59). Cleaning the ear canal would 
prolong the testing time but would ultimately result in fewer false positives requiring a repeat 
OAE.  
Khoza-Shangase et al recommend that in order for more neonates to be assessed and for 
confounding factors such as the presence of vernix caseosa to be minimised, screening should 
take place on day three of life at the Midwife Outpatient Unit. Their findings show that more 
neonates were screened and fewer false positive findings were present on day three of life 
compared to within a few hours post delivery. This could be attributed to the vernix caseosa 
being removed from the outer ear canal (44). This would be difficult to implement in our facility 
as our neonates who are born vaginally are typically discharged within a couple of hours from 
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delivery. Similar findings were reported by Tsui et al who described delaying diagnostic ABR 
by up to 50 days post delivery of the neonate, improved the specificity of the hearing assessment. 
This was again postulated to be secondary to the spontaneous removal of vernix in the ear canal 
or the improvement of any other middle ear pathology, such as middle ear effusions (60). The 
disadvantages of delaying the hearing screening are that there could potentially be a delay in the 
detection of hearing loss, as well as the potential emotional stress to the caregivers as they await 
the hearing assessment (60). The possible anxiety experienced by the caregivers from delaying 
the assessment needs to be weighed against the potential anxiety caused by a false positive result 
on hearing screening, which may inhibit the bonding between mother and child (18). 
5.2.5 Early discharge of neonates from the ward 
Screening neonates born afterhours via normal vaginal delivery was an anticipated difficulty, as 
these mothers are typically observed for six to eight hours post-delivery and then discharged 
home. A possible solution to this would be if the audiologists had a larger team who could then 
screen at two time intervals during the day, or if alternate health care professional were trained 
to conduct the screening test.  
The second group of neonates who were not screened was those that were born over the 
weekends and were discharged home before being enrolled into the study. This limitation, set 
by the non-availability of staff to conduct screening over the weekend, was a major factor when 
assessing the feasibility of UNHS.  
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5.3 Refer results 
Repeat testing was required for 57 (47%) neonates, however only 20 infants returned for repeat 
DPOAE. This referral rate of 47% after initial screening is much higher than the HPCSA’s 
recommendation of  <5% (14), which is in agreement with the guidelines from the JCIH that 
less than four percent of all newborns should fail the initial screening and be referred for repeat 
screening (9). No significant risk factors were found within the group requiring repeat DPOAE. 
The target referral rate is a means of applying quality-control to the screening program (5). The 
high refer rates may have been attributed to inappropriate testing circumstances with excessive 
ambient noise interference, the presence of vernix and the faulty DPOAE machine. The high 
referral rate of 47% also contributed to increasing the burden of work for the under-resourced 
screening team.   
There were no infants found to have a hearing impairment and therefore the rate of true versus 
false positive results could not be determined. 
 
5.4 Risk factors 
A recent South African study by Le Roux et al retrospectively reviewed 264 pediatric patients 
who had received cochlear implants, and assessed the diagnosis and associated risk factors. They 
reported that a positive family history of hearing loss, admission to NICU, and prematurity were 
significant risk factors for profound hearing loss (19). Although these risk factors were present 
in the screened cohort, no neonates were found to have impaired hearing. The infant who 
defaulted on the third OAE, had no significant risk factors on history, and was a well term 
neonate who had delivered vaginally. 
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5.5 Loss to follow-up 
After the initial screening, 57 neonates were due to come back for a repeat OAE with only 20 
(35%) returning for follow-up. In addition to this, of the two that required an ABR, only one 
returned for follow-up. An information sheet was explained and given to the mother or caregiver 
when they were counseled after the first DPOAE had not been passed. The importance of repeat 
testing may not have been made clear to the mothers and this lack of understanding could have 
contributed to the poor follow-up rate.  
The time during which pregnant mothers wait in the antenatal queue is being utilised at some 
clinics to counsel the mothers and educate them about various health issues such as the 
importance of breastfeeding and knowing their HIV status. An ideal time to adequately counsel 
the mothers regarding the importance of the screening test would be at an antenatal visit. 
Expectant mothers’ knowledge regarding their babies care was improved by short sessions of 
antenatal education, as was demonstrated by Weiner et al in Vientiane, Laos (61).   
Another possible reason for the poor follow-up rate may be due to financial limitations as these 
families may not have been able to afford the cost of travel to return to the hospital. The 
associated costs and lack of knowledge of the caregivers were found to be the two most common 
reasons for defaulting follow-up appointments for rescreening in a South African study (62). 
Improved counselling and communication, as well as proactive reminders decreases the loss to 
follow-up rate. The return rates would most likely improve if the follow-up screening, or 
diagnostic testing, was on the same day as the visit to the local clinic for immunisations, or on 
the same day as the neonatal follow-up appointment (63). Community-based screening 
programmes in the Western Cape have been found to be effective in improving the rate of 
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follow-up (52). In the Western Cape study, Friderichs et al utilised clinic nurses to screen infants 
at their routine clinic immunisation visits. A two-stage DPOAE screening process was 
implemented, which was similar to the screening process utilised by our study except that the 
timing of administration differed. If the initial DPOAE was a refer result, a second DPOAE was 
administered four weeks later at the 14 week immunisation clinic visit. If this was again a refer 
result, the infant would be referred for a diagnostic ABR. This method of screening was highly 
effective in improving follow-up rates, but the disadvantage was that dedicated screening 
personnel were required to implement the screening test. 
With such a high rate of false positives being detected and resulting in unnecessary follow-up 
for the patients, the importance of having an ideal testing scenario for the initial screening test 
is emphasised. Ideally, what would be required is a testing environment with low ambient noise 
levels, reliable equipment, and staff trained to perform the necessary testing. A study in Greece 
demonstrated that by conducting OAE testing at birth and again prior to discharge of the 
neonate, unnecessary high referral rates were prevented (64). This was possible in the study 
setting as neonates typically stay at least four days in hospital post delivery (64). 
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5.4 Study limitations 
 The main limitation of the current study was that the time period used for data collection 
was limited to three months due to the fact that this was a study in partial fulfillment of 
a degree where limited time period was available. It is believed that a longer time frame 
where other variables could have come into play might have influenced the findings of 
the study.  
 The second limitation is that the study was in one hospital in Johannesburg where 
resources are significantly better than in a number of other hospitals in the country; 
therefore generalizability of the findings is limited.  
 The last limitation; which also has implications for generalization of the findings; is the 
small sample size, although this would not have altered the primary study outcome 
which was to assess the number of neonates who could be successfully screened.  
 
It is important therefore that current findings be interpreted with these limitations in mind; and 
that future studies consider these in their study design.  
 
6.0 Conclusion 
Conducting a Universal Newborn Hearing Screening programme was not feasible at RMMCH, 
a secondary level hospital in Gauteng South Africa. The most important limitations to the 
feasibility were the insufficient number of audiologists available to provide screening, the high 
rate of false positive test results, and the unacceptably high rates of loss to follow-up. Two 
 48 
 
modifiable factors, namely the presence of vernix caseosa in the external ear canal and high 
ambient noise levels were found to have significantly impacted on the testing process. Further 
research is required to determine the constituents for a successful screening programme in the 
South African context. 
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7.0 Recommendations 
 A local screening programme should be developed that is appropriate and feasible for 
the South African context. 
 UNHS is currently not feasible in our secondary level hospital and so targeted screening 
for those considered at high risk of a hearing impairment should be implemented as an 
interim measure. 
 Further research needs to be conducted to better define risk factors in the context of 
resource-constrained countries. 
 To improve the overall refer rates to an acceptable level i.e. < 5% as per HPCSA EHDI 
guidelines, necessary steps should be taken to improve the testing environment. This 
entails limiting the ambient noise levels and removing any debris or vernix caseosa from 
the neonate’s ear prior to testing.  
 Research into the possibility of training nursing personnel, who are available afterhours, 
in the use of the OAE machine in order to implement screening. Another possibility is 
the future training of Audiology technicians. 
 Public awareness, especially for the expectant mothers and medical personnel, needs to 
be improved with regards to the importance of hearing screening. This can be 
implemented as part of the essential education available to mothers in the antenatal 
clinics. 
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Information Sheet for feasibility assessment of Universal Newborn 
Hearing Screening programme at Rahima Moosa Mother and Child 
Hospital 
 
 
Dear Parent/Caregiver 
Hello. My name is Dr Jacqui Bezuidenhout and I am a doctor working in the Paediatric department. We are 
conducting a study at Rahima Moosa Mother and Child Hospital, looking at the number of newborn babies born 
with hearing problems and would like to include your baby. 
Hearing is essential for normal speech and language development, and if left untreated, can result in the child not 
reaching their full potential. For the best outcome, babies with hearing losses should be fitted with a hearing aid by 
six months of age. 
We will be using a machine called an otoacoustic emission device which sends a sound wave into the ear which 
tells us how the inner ear is functioning. It is completely painless and can be completed within a few minutes. If the 
baby passes the tests you will not need to have any further testing of the ears, but if the baby does not pass the 
test we will need to retest the baby within a month. If the baby again does not pass the test, we will refer the baby 
to Charlotte Maxeke Johannesburg Academic hospital for further testing. If a hearing deficit is found, and 
depending on the type and severity of hearing loss present, a suitable hearing assistive device will be provided by 
Rahima Moosa Mother and Child hospital’s speech and hearing department.  
With your permission, we would like to use information from your baby’s file including if available, your HIV status. 
This information is going to help us in understanding which babies are more at risk of having hearing losses. The 
information will be kept confidential, and you or your child’s identity will not be revealed to anyone. The results of 
this study will be shared with other doctors and audiologists looking after babies with hearing losses. 
Although there will be no financial benefit in participating in this study, your baby if detected to have a hearing loss 
will benefit from early intervention and provision of an appropriate hearing assistance device. You are free to 
withdraw from the study at any time if you change your mind and this will not affect your child’s hospital care in 
any way.  
There are no risks associated with the use of an OAE machine to test for hearing losses, but should you feel any 
anxiety or distress if your child has an inconclusive result or a definite hearing problem, psychological counseling 
will be provided by our psychologists. 
Should you have any questions, please feel free to contact the researcher, Dr J Bezuidenhout at Rahima Moosa 
Hospital on 011 470 9144 
Thank you 
 
 
Appendix A – Information sheet 
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Appendix B – Consent form 
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Appendix C – Image of DPOAE machine utilized for screening at RMMCH 
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Rahima Moosa Hospital - Otoacoustic emission (OAE) Screening 
Form 
 
General information 
Study no  Location Ward 7   8  16  Date of 
exam 
         /        /  2012 
Mode of delivery  NVD    C/S   Assisted HIV exposed?  Yes        No    Unknown 
Apgar scores 1’  5’  10’  Birth weight (g)  
 
Risk Factor assessment 
Family history of permanent 
childhood hearing loss? 
Yes                No 
Admitted to NICU? Yes                No 
Duration of NICU stay? 
(Days) 
 
Assisted ventilation? Yes                No 
Exposure to ototoxic drugs 
(aminoglycosides/loop diuretics)? 
Yes                No 
Hyperbilirubinaemia requiring 
exchange transfusion? 
Yes                No             Highest bilirubin documented_____ 
Congenital infections? CMV Herpes Toxo Rubella Syphilis HIV Malaria None 
Craniofacial abnormalities? Yes                No 
 
A. Initial Screening 
1. Otoscopic examination 
 Vernix Narrow canal  NAD   
Right      
Left      
 
2. OAE 
 Right Left 
1000kHz   
2000kHz   
3000kHz   
4000kHz   
5000kHz   
Appendix D – Data collection form 
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Plan and outcome 
Time taken Start time:………….  End time:…………..   Examiner’s initials:   ………. 
Challenges Vernix Equipment Noise Other (Specify) 
Plan Discharge Repeat OAE Other (specify) 
 
B. Repeat Screening 
1. Otoscopy 
 Vernix Narrow canal  NAD   
Right      
Left      
 
2. Tympanometry 
 Right Left 
Ear canal volume cm3                               cm3 
Static compliance cm3                               cm3 
Pressure daPa daPa 
Type   
 
3. OAE 
 Right Left 
1000kHz   
2000kHz   
3000kHz   
4000kHz   
5000kHz   
Plan and outcome 
Time taken Start time:………….  End time:…………..   Examiner’s initials:   ………. 
Challenges Wax Equipment Noise Other (Specify) 
Plan Discharge ABR Other (specify) 
 
C. ABR result 
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Appendix E – HREC clearance certificate 
